DCF Advisers, LLC latest Q1_2021 13F filings reported $197,046,000 in market value on this 2021-05-12 report date . The portfolio quarterly return is 5.20%. This fund has 81 securities concentrations of 100% weights.
DCF Advisers, LLC largest holding is Intra-Cellular Therapies Inc. with weight of 7.31% and $14,403,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.